# Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery

> **NCT00308126** · PHASE4 · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 624 (—)

## Conditions studied

- Postoperative Complications

## Interventions

- **DRUG:** Hydroxyethyl Starch 130/0.4 (Voluven)

## Key facts

- **NCT ID:** NCT00308126
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 624 (—)
- **Last updated:** 2007-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308126, "Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00308126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*